$BIRD Cashflow Statement | Understand Stock

$BIRD

$2.11 -$0.04 (1.86%) Close

$BIRD Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Amortization of debt issuance costs
Stock-based compensation
Warrant expense
Inventory write-down
Loss on disposal of assets
Deferred taxes
Impairment expense
Change in fair value of preferred stock warrant liability
Realized loss on equity investment
Net loss from sales of businesses
Gift card breakage
Changes in assets and liabilities:
Accounts receivable
Inventory
Prepaid expenses and other current assets
Operating lease right-of-use assets and current and noncurrent lease liabilities
Accounts payable and accrued expenses
Other long-term liabilities
Deferred revenue

Net cash used in operating activities
Cash flows from investing activities:
Purchase of property and equipment
Investment in equity securities
Proceeds from sale of equity investment
Proceeds from sales of businesses
Changes in security deposits
Net cash (used in) provided by investing activities

Cash flows from financing activities:
Proceeds from the issuance of preferred stock, net of issuance costs
Payment of debt issuance costs
Proceeds from bank loans
Principal payments on bank loans
Payments of deferred offering costs
Repayment of non-recourse promissory note
Proceeds from line of credit
Payments on line of credit
Proceeds from the issuance of common stock
At-The-Market
2021 ESPP
Total proceeds from the issuance of common stock
Proceeds from the exercise of common stock warrants
Proceeds from the exercise of stock options
Other
Taxes withheld and paid on employee stock awards
Payment of deferred financing costs
Net cash provided by financing activities

Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash
Net decrease in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash—beginning of year
Cash, cash equivalents, and restricted cash—end of year
Supplemental disclosures of cash flow information:
Cash paid for interest
Cash paid for taxes
Noncash investing and financing activities:
Purchase of property and equipment included in accrued liabilities
Repurchase of stock options
Non-cash exercise of common stock warrants
Deferred offering costs included in accrued liabilities
Stock-based compensation included in capitalized internal-use software

Reconciliation of cash, cash equivalents, and restricted cash:
Cash and cash equivalents
Restricted cash included in prepaid expenses and other current assets

Comments